Migraine Drugs Market is expected to increase at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2035

 

The market for migraine drugs market was estimated to be worth USD 5.9 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 6.4% to reach USD 9.6 billion in 2035. Migraine medications provide a variety of patient-specific therapeutic choices. The market is sustainable and expanding since it is in line with the healthcare industry.

Migraine is a prevalent and debilitating neurological condition marked by severe, recurrent headaches that are frequently accompanied by light and sound sensitivity, nausea, and vomiting. Prodrome, aura, attack, and post-drome are the four stages that migraine symptoms can go through, affecting both adults and children. Both acute abortive and preventive/prophylactic medications are used in the therapy of migraines.

 

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/migraine-drugs-market

 

GROWTH DRIVERS

The market is largely driven by the increasing prevalence of migraines, which raises the need for efficient treatment. A JAMA Network report states that total migraine incidence rose by 34% for men and 56% for women. Women between the ages of 20 and 29 experienced the greatest rate of rise, with 600 to 1,000 new cases per 100,000 women annually. The NCBI estimates that there were 1.1 billion migraine cases worldwide in 2019, a 1.7% rise in prevalence between 1990 and 2019. Males and those between the ages of 10 and 14 showed the greatest increase in incidence, whereas females and those between the ages of 20 and 24 had the highest prevalence and DALYs.

Global healthcare costs skyrocketed from 7.4% in 2022 to a record high of 10.7% in 2023, according to Becker and WHO. Globally, the insurer-reported cost trend for 2024 is expected to be 9.9%, while some areas will witness a more rapid rise. The growth in health spending to a record high of USD 9 trillion, or almost 11% of global GDP, was driven by a substantial increase in government spending on health across all income levels.

MARKET SEGMENTATION:

·         By Type- Acute/Abortive Treatment (Analgesic, Ergotamine, Triptans), Preventive/P Treatment (Beta Blockers, Anti-serotonergic drugs, anti-depressants, anticonvulsants, calcium channel blockers)

·         By Route of Administration- Oral, Injectable (Pre-filled Syringes, Vial)

·         By Distribution Channel- hospital pharmacies, retail pharmacies and online pharmacies

·         By Region- North America, Europe, Asia Pacific, The Middle East and Africa, South America

Global Key Players:

·         Novartis AG

·         AstraZeneca

·         Amgen Inc.

·         Abbvie

·         Glaxo SmithKline plc

·         Eli Lilly and Compnany

·         Abbott Laboratories

·         Teva Pharmaceuticals Industries

·         Pfizer

·         Merck & Co. Inc

·         Bausch Health Companies

·         Janssen Pharmaceutical Company

·         Biohaven Pharmaceutical Holding Company

·         Endo Pharmaceutical

·         Other Players

 

For More Information about this Report @ https://www.xresearch.biz/shop/migraine-drugs-market

 

About Us: -  

xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

                                   

Contact:                                           
Company Name: 
xResearch
Contact Person:  James Lin
Email: 
sales@xresearch.biz
Phone: +1 718-619-8140

Websites: https://www.xresearch.biz/


Comments

Popular posts from this blog

Microalgae Fertilizers Market is expected to increase at a compound annual growth rate (CAGR) of 12.1% from 2025 to 2035

Food Encapsulation Market is predicted to expand at a compounded annual growth rate (CAGR) of 6.8% during the forecast period

Food Thermometer Market is expected to increase at a compound annual growth rate (CAGR) of 15.3% from 2025 to 2035